365 related articles for article (PubMed ID: 8264643)
1. Expression and function of TRK-B and BDNF in human neuroblastomas.
Nakagawara A; Azar CG; Scavarda NJ; Brodeur GM
Mol Cell Biol; 1994 Jan; 14(1):759-67. PubMed ID: 8264643
[TBL] [Abstract][Full Text] [Related]
2. Expression of TrkA, TrkB and TrkC in human neuroblastomas.
Brodeur GM; Nakagawara A; Yamashiro DJ; Ikegaki N; Liu XG; Azar CG; Lee CP; Evans AE
J Neurooncol; 1997 Jan; 31(1-2):49-55. PubMed ID: 9049830
[TBL] [Abstract][Full Text] [Related]
3. Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma.
Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
Eur J Cancer; 1997 Oct; 33(12):2058-63. PubMed ID: 9580079
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction pathways through TRK-A and TRK-B receptors in human neuroblastoma cells.
Sugimoto T; Kuroda H; Horii Y; Moritake H; Tanaka T; Hattori S
Jpn J Cancer Res; 2001 Feb; 92(2):152-60. PubMed ID: 11223544
[TBL] [Abstract][Full Text] [Related]
5. trk A gene expression in neuroblastoma. The clinical significance of an immunohistochemical study.
Tanaka T; Hiyama E; Sugimoto T; Sawada T; Tanabe M; Ida N
Cancer; 1995 Sep; 76(6):1086-95. PubMed ID: 8625212
[TBL] [Abstract][Full Text] [Related]
6. Expression and function of the nerve growth factor receptor (TRK-A) in human neuroblastoma cell lines.
Azar CG; Scavarda NJ; Nakagawara A; Brodeur GM
Prog Clin Biol Res; 1994; 385():169-75. PubMed ID: 7972209
[TBL] [Abstract][Full Text] [Related]
7. Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y.
Encinas M; Iglesias M; Llecha N; Comella JX
J Neurochem; 1999 Oct; 73(4):1409-21. PubMed ID: 10501184
[TBL] [Abstract][Full Text] [Related]
8. Glial cell line-derived neurotrophic factor/neurturin-induced differentiation and its enhancement by retinoic acid in primary human neuroblastomas expressing c-Ret, GFR alpha-1, and GFR alpha-2.
Hishiki T; Nimura Y; Isogai E; Kondo K; Ichimiya S; Nakamura Y; Ozaki T; Sakiyama S; Hirose M; Seki N; Takahashi H; Ohnuma N; Tanabe M; Nakagawara A
Cancer Res; 1998 May; 58(10):2158-65. PubMed ID: 9605760
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of Trk-C in favourable human neuroblastomas.
Yamashiro DJ; Liu XG; Lee CP; Nakagawara A; Ikegaki N; McGregor LM; Baylin SB; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):2054-7. PubMed ID: 9516852
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of messenger RNA for TRK protooncogene and low affinity nerve growth factor receptor in neuroblastoma with favorable prognosis.
Kogner P; Barbany G; Dominici C; Castello MA; Raschellá G; Persson H
Cancer Res; 1993 May; 53(9):2044-50. PubMed ID: 8481906
[TBL] [Abstract][Full Text] [Related]
11. Activation of trk-A but not trk-B signal transduction pathway inhibits growth of neuroblastoma cells.
Lucarelli E; Kaplan D; Thiele CJ
Eur J Cancer; 1997 Oct; 33(12):2068-70. PubMed ID: 9516854
[TBL] [Abstract][Full Text] [Related]
12. Association between high levels of expression of the TRK gene and favorable outcome in human neuroblastoma.
Nakagawara A; Arima-Nakagawara M; Scavarda NJ; Azar CG; Cantor AB; Brodeur GM
N Engl J Med; 1993 Mar; 328(12):847-54. PubMed ID: 8441429
[TBL] [Abstract][Full Text] [Related]
13. Unliganded c-erbA/thyroid hormone receptor induces trkB expression in neuroblastoma cells.
Pastor R; Bernal J; Rodríguez-Peña A
Oncogene; 1994 Apr; 9(4):1081-9. PubMed ID: 8134111
[TBL] [Abstract][Full Text] [Related]
14. Lack of high-affinity nerve growth factor receptors in aggressive neuroblastomas.
Suzuki T; Bogenmann E; Shimada H; Stram D; Seeger RC
J Natl Cancer Inst; 1993 Mar; 85(5):377-84. PubMed ID: 8433391
[TBL] [Abstract][Full Text] [Related]
15. Transfection of TRK-A into human neuroblastoma cells restores their ability to differentiate in response to nerve growth factor.
Lavenius E; Gestblom C; Johansson I; Nånberg E; Påhlman S
Cell Growth Differ; 1995 Jun; 6(6):727-36. PubMed ID: 7669728
[TBL] [Abstract][Full Text] [Related]
16. Expression of brain-derived neurotrophic factor and p145TrkB affects survival, differentiation, and invasiveness of human neuroblastoma cells.
Matsumoto K; Wada RK; Yamashiro JM; Kaplan DR; Thiele CJ
Cancer Res; 1995 Apr; 55(8):1798-806. PubMed ID: 7712490
[TBL] [Abstract][Full Text] [Related]
17. Expression of trkA cDNA in neuroblastomas mediates differentiation in vitro and in vivo.
Matsushima H; Bogenmann E
Mol Cell Biol; 1993 Dec; 13(12):7447-56. PubMed ID: 8246962
[TBL] [Abstract][Full Text] [Related]
18. Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.
Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
Prog Clin Biol Res; 1994; 385():137-45. PubMed ID: 7972205
[TBL] [Abstract][Full Text] [Related]
19. Constitutive phosphorylation of TrkC receptors in cultured cerebellar granule neurons might be responsible for the inability of NT-3 to increase neuronal survival and to activate p21 Ras.
Zirrgiebel U; Lindholm D
Neurochem Res; 1996 Jul; 21(7):851-9. PubMed ID: 8873090
[TBL] [Abstract][Full Text] [Related]
20. Role of neurotrophins and their receptors in human neuroblastomas: a primary culture study.
Nakagawara A; Brodeur GM
Eur J Cancer; 1997 Oct; 33(12):2050-3. PubMed ID: 9516851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]